Simple skin care may shield kids from cancer drug side effects
NCT ID NCT04479514
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a preventive skin care routine in 14 children (ages 6 months to 18 years) with brain tumors who were receiving targeted therapy (BRAF, MEK, or Pan-RAF inhibitors). The goal was to see if gentle skin care and sun protection could reduce or prevent skin reactions caused by these drugs. The approach included daily moisturizing, sun avoidance, and mild cleansers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can a shorter chemo combo tame High-Risk neuroblastoma?
- Virtual companion 'Ida' may ease cancer distress in kids
- Can a Child's own words improve cancer care?
- Can off-label cancer drugs help children? a national study aims to find out